KYRNF vs JNJ: Which Stock is Better?

Side-by-side comparison of KYORIN Pharmaceutical Co., Ltd. and Johnson & Johnson in 2026

Comparison Updated:

KYRNF

KYORIN Pharmaceutical Co., Ltd.

$10.31

JNJ

Johnson & Johnson

$234.18

Key Metrics Comparison

MetricKYRNFJNJWinner
Market Cap$592.33M$565.22BJNJ
P/E Ratio10.1121.26KYRNF
EPS (TTM)$1.02$11.03JNJ
Revenue Growth-0.0%0.1%JNJ
Gross Margin45.3%68.0%JNJ

Analyze KYRNF

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KYRNF or JNJ a better investment?

Comparing KYRNF and JNJ: KYORIN Pharmaceutical Co., Ltd. has a market cap of $592.33M while Johnson & Johnson has $565.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KYRNF and JNJ?

KYRNF (KYORIN Pharmaceutical Co., Ltd.) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KYRNF or JNJ?

Based on P/E ratios, KYRNF trades at a lower multiple (10.1x vs 21.3x).

Which is growing faster: KYRNF or JNJ?

JNJ has higher revenue growth at 0.1% vs -0.0% for KYRNF.

Which company is more profitable: KYRNF or JNJ?

Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 45.3% for KYRNF.

Which is the larger company: KYRNF or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $565.22B compared to $592.33M for KYRNF.

Should I buy KYRNF or JNJ in 2026?

Both KYRNF and JNJ have investment merit. KYRNF trades at $10.31 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KYRNF and JNJ stock?

Key differences: Market Cap ($592.33M vs $565.22B), P/E Ratio (10.1x vs 21.3x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (45.3% vs 68.0%).

Popular Stock Comparisons